Alternative Health looks at alternative ways of treating illness apart from the medical system.
War on Drugs: Government Approves Patented Synthetic THC but Still Classifies Natural Cannabis as Dangerous and Illegal
The pharmaceutical industry is pulling out the stops lobbying government officials and influencing those that are inclined toward prohibition, to protect not only their synthetic THC interests but also their vast exclusive pharmaceutical market. Increased cannabis use is intruding on the pharmaceutical industry's turf. It has been implied and most of us could see it coming, but on November 22, 2017, it became official. The DEA placed synthetic THC, Dronabinol, the medicinally powerful compound that creates the high in marijuana, as a Schedule II controlled substance, yet whole plant cannabis remains as a Schedule I controlled substance. The most basic irony is the idea of synthetically creating one compound of a natural plant and making it legal for medical applications while banning the plant from which it was copied synthetically, even making its use illegal. Unfortunately, this is business as usual with the pharmaceutical industry.
Chlorella is a super-food that offers so many detoxification and health boosting qualities that it is hard to imagine how or why it seems to be under the radar for many holistic health advocates. Chlorella is single cell algae that can be produced in open pools of fresh water with lots of exposure to sunlight. Since each cell can only be seen through a microscope, it is categorized as a microalgae. Researchers in the West have become increasingly aware of its extremely high nutrient density over the past 100 plus years. In 2016, the journal Current Pharmaceutical Design published a review, Chlorella vulgaris: A Multifunctional Dietary Supplement with Diverse Medicinal Properties. They stated: "Clinical trials have suggested that supplementation with C. vulgaris can ameliorate … hyperglycemia, and protect against oxidative stress, cancer and chronic obstructive pulmonary disease." Chlorella is not some sort of exaggerated super-food fad; chlorella could replace a lot of supplements that are not as natural.
The least publicized actual side effect of cholesterol-lowering statin drugs that complements the dangerous intended effect of reducing cholesterol is they also block CoQ10 production, which is already waning among those aged 40 and older. That’s the age when people begin getting prescribed statins per the newest statin drug guidelines. The irony is that CoQ10 is vital for good heart health! CoQ10 is on high demand from cells in muscle tissue, and the muscle that works the most without rest is the heart. Instead of supplementing CoQ10 when one reaches the 40 year plus mark, he or she will likely be prescribed statin drugs for life as a preventative against cardiovascular disease and heart attack. As statin drugs decrease one’s already lowered CoQ10 production from aging, the heart can get slowly weaker, leading to congestive heart failure. This is when the heart keeps beating, but it is so weak it isn’t strong enough to maintain blood flow throughout to meet the body's needs. Instead of the pain that accompanies a sudden heart attack, gradually one begins to have less and less energy. Excessive tiredness comes in that may be incorrectly attributed to aging or being out of shape. Exercise only further exposes one’s breathing problems. Distended belly and leg swelling also occur. This can go on for years with increasing disability until there is a total heart failure. The newest guidelines for statins almost require physicians to put patients on statins as a preventative practice for life. As the CoQ10 deficiency worsens from statins, the poor patient goes into a debilitating spiral without any recognition to its true cause.
A group of independent medical academics challenged a BMJ (British Medical Journal) 20 year follow-up study that claimed favorable results among those using statins as a preventative measure. It was known as the West of Scotland Coronary Prevention Study (WOSCOPS), and it was the first trial to demonstrate a significant reduction in cardiovascular events with statin therapy for primary prevention. The critical report challenging the BMJ’s statin-promotion based on the WOSCOPS study was published recently, October of 2017. The challenging trio of medical scientists, led by independent researcher Uffe Ravnskov MD, PhD, author of The Cholesterol Myth and Fat and Cholesterol are Good for You, parsed and picked at the study to show it is flawed. They concluded: "The study has serious bias. Many patients stop taking statins. In a study of over 140 000 elderly people, two thirds of those with cardiovascular disease (and even more of those without) had stopped treatment after two years. The question is, therefore, whether the mortality benefit among those with the highest LDL cholesterol is due to statin treatment or to their high LDL cholesterol. The question is relevant because a recent systematic review of 19 cohort studies including 68 094 elderly people (≥60 years) followed for several years found an inverse association between all cause mortality and LDL cholesterol in 92% of participants. In the largest study those with the highest LDL cholesterol lived longer than those taking statins."
Study: Black Seed Oil Helps Parkinson’s – Can be Used for Anti-depressant and Anti-anxiety Treatment
A recently studied virtue of black cumin oil is its positive effects on neurological and psychiatric systems. A meta-study of several studies analyzing black cumin for several neurological applications includes “… the pharmacological actions and the therapeutic potential pertaining to the central nervous system, particularly effects on psychiatric and neurological dysfunctions, …” The meta study, Neuropsychiatric Effects of Nigella sativa (Black Seed) A Review was published in the journal Alternative and Integrative Medicine. It reviews in detail studies from international sources where researchers have observed positive results from black cumin seed. The researchers reviewed articles published on studies about the effects of Nigella Sativa, its oil and active components, on various clinical conditions concerning the central nervous system. The black cumin seed positive-effect pharmacological categories are: Anti-convulsant effects from epilepsy, Anti-Parkinson's effects, Neuroprotective effects, Anti-depressant effects, Anti-anxiety effects, Effects on improving learning and memory, Effects on drug tolerance and drug dependence, Effects on encephalitis, toxoplasmosis and malaria, which both affect the brain
You’re not alone in your thyroid struggles. Challenged by symptoms, frustrated with testing or even if you already have a firm diagnosis, the experts participating in the Healing Hashitmoto's Summit can help you. Thyroid disorders can overreact to the slightest of imbalances — join us and gain the advice you need to live a happy, healthy life with Hashi’s! Just like you, most of the co-hosts of this summit have Hashi’s — join them online to assist in your path towards wellness. They’ve done it, and you can too! You’ll learn from their personal stories, plus the advice, tips and in-clinic practices from the experts they’ve relied on, not just to diagnose and manage this disease, but to live with hope, purpose and companionship!
While it is not ideal for a newborn infant to catch whooping cough, it can be managed at home. Successful treatment will require diligence and an adult rocking very young infants, at the peak of infection, 24 hours for several days. Babies cannot get vaccinated until they are two months of age, and by then, the cough can be treated much more easily than in a younger infant. After three months, a fully breast-fed baby will respond well. Otherwise healthy babies over six months of age with whooping cough, should not worry any parent if they understand the principles and protocols to deal with the infection, and are well equipped and organized. B.pertussis bacteria is very tricky, and part of its armor involves several toxins. Toxin production is the major reason for the worst symptoms. Conventional medical doctors don’t know how to address the toxin issue in most infections. They give antibiotics, which have never been shown with any certainty, to limit the duration or severity of whooping cough in well-established disease. Is ascorbate a cure? No, but the majority of parents who use it on their infected babies, and young and older children, report a significant decrease in cough intensity, with thinning and loosening of sticky mucus, within the first 24 hours of proper dosing. Ascorbate, in properly spaced, very high oral doses, will get you and your children through the weeks with vastly reduced symptoms while developing lasting immunity that will later protect those around them more effectively than vaccines can.
A recently published study (October 2017) challenges the accepted mainstream medical theory that ovarian cancer is developed in the ovaries. The study, "Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma," was conducted by medical researchers in 2016 at both the Sloan-Kettering Cancer Institute and Johns Hopkins. The study contends that, "For decades it was thought that ovarian carcinoma originates in the OSE or ovarian CICs, but few data supported this claim. Lesions resembling an intraepithelial carcinoma in CICs and the OSE are rare. In contrast, a putative precursor of ovarian carcinoma has been described in the fallopian tube, designated STIC, which is found frequently in association with “ovarian” HGSCs and in the fallopian tubes removed prophylactically from high-risk women. The implications of these findings are to direct efforts for prevention and early detection toward the distal fallopian tube, rather than the OSE. Ongoing and planned clinical trials are investigating bilateral salpingectomy with ovarian preservation as a viable option for ovarian cancer risk-reduction." Women are often encouraged to have their ovaries removed during an existing pelvic operation to ensure protection against ovarian cancer. Dr. Robert J. Rowen, M.D. is questioning the need for such surgeries in light of this new study. The result of surgically removing ovaries, for millions of women, according to Dr. Rowen, has been: “… a nightmare of hormonal difficulties. The ovaries do, in fact, make some hormone even after menopause and all the eggs are gone.”
We must keep the FDA from turning a vital nutrient over to Big Pharma. An important study finds that carbidopa, a standard Parkinson’s drug, “irreversibly binds to and permanently deactivates” pyridoxal-5’-phosphate (P5P), a key form of vitamin B6 in the body. The authors describe the essential role P5P plays in the body: “[P5P] is required for the function of over 300 enzymes and proteins. Virtually every major system of the body is impacted directly or indirectly by [it].” You’re not likely to hear from a conventional doctor how this drug destroys a vital nutrient in your body, just as you’re unlikely to hear how a host of other drugs interfere with the body’s absorption of key vitamins and minerals. (The FDA hasn’t approved alternative therapies for Parkinson’s, such as focused ultrasound, even though it is approved for similar conditions.) Actually, the FDA would prefer you to take your B6 in the form of a drug. You may recall the case of pyridoxamine, one of three bioavailable forms of vitamin B6. This vitamin has many health benefits; indeed, we could not live without B6. Notwithstanding, in 2009 the FDA banned the supplement form of pyridoxamine in response to a petition from a drug company, which wanted to use it in a drug formulation. P5P faces a similar threat. The FDA is considering a petition from Medicure Pharma to ban P5P because the company wants to turn this crucial vitamin into a drug. This is especially scary—all forms of B6, natural or synthetic, must be converted to P5P for the body to use them. If the FDA approves the petition, anyone who is not able to convert synthetic B6 to P5P would have to rely solely on Medicure’s product to stay alive.
Mainstream Medicine Admits Medical Cannabis is Effective in Treating Leukemia – But Only Synthetic Patented Version
There has been a bit of a stir recently over mainstream medical analysis that supports cannabis for treating leukemia. Unfortunately, most of it involves cannabis as an adjunct or supporting treatment for chemotherapy, while the rest supports synthetic THC for leukemia. An example of this is a 2016 study referenced in a June 2017 issue of Herb in the article “Is Cannabis Effective Against Leukemia,” which surprisingly cautiously skirted the issue of curing leukemia with cannabis. The study referenced, "Dronabinol has preferential anti-leukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns," which basically examined the efficacy of a pharmaceutical drug called dronabinol, the active synthetic THC compound of Marinol . The study was very favorable, concluding: "Our study provides rigorous data to support clinical evaluation of THC as a low-toxic therapy option in a well defined subset of acute leukemia patients." So this synthetic THC drug dronabinol is okay with the FDA, and the DEA has it listed as a Schedule III controlled substance. Yet the whole plant cannabis commonly known as marijuana with its balanced assortment of 80 or so cannabinoids and terpenes and flavonoids that contribute to a safe synergistic entourage effect of healing is still listed as Schedule I, dangerous, addictive, and without medical merit.